Diamedica Therapeutics Inc (DMAC)

Total Costs & Expenses

$38.86M

TTM · Period ending: · USD

DMAC logo

DMAC Total Costs & Expenses

Latest reported$38.86M
DMAC TTM Total Costs & Expenses (-$155.33K → $38.86M)
High-resolution chart · PNG

DMAC total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Diamedica Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
38,860,000
36,735,000
34,397,000
33,603,000
31,453,000
29,084,000
26,681,000
24,110,000
22,384,000
21,487,000
21,267,000
19,392,000
17,363,000
15,986,000
14,001,000
13,274,000
13,562,000
13,563,000
13,646,000
14,668,000
14,571,000
13,914,000
12,699,000
11,201,000
10,543,000
10,576,000
11,593,000
8,819,343
8,145,343
7,254,343
5,139,343
6,306,296
5,039,603
4,288,446
4,275,000
3,719,856
3,962,582
3,415,888
2,494,988
2,335,296
1,550,616
1,322,757
1,356,422
1,673,232
2,376,244
3,301,107
4,941,359
5,381,728
5,811,840
6,752,002
7,420,756
9,238,854
10,519,447
10,869,550
10,012,462
8,981,175
8,153,408
7,140,059
6,914,104
6,627,663
5,836,742
4,938,061
3,725,177
2,526,664
2,167,489
2,027,293
2,243,318
1,893,860
1,980,710
2,146,363
1,978,565
2,486,050
2,239,312
2,654,281
2,364,671
1,915,539
1,660,071
592,257
415,242
146,030
-105,415
-155,331
-155,331
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.